Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22
Phase 31

Trial Status

Recruiting1
Terminated1
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT05952947Phase 1Recruiting
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
Anal CancerCarcinoma of PenisCarcinoma of Vagina+3 more
PrincipalinvestigatorStart date: 2023-11-01
NCT05357027Phase 1/2Terminated
HPV16 E6 TCR T Cells for Cervical Carcinoma
Cervical Carcinoma
StudydirectorStart date: 2022-08-10

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jian Zhang, Doctor

Fudan University

Similar
7 trials

Shared therapeutic areas:

Carcinoma of PenisCarcinoma of VulvaCancer of the Uterine Cervix+3 more

Worked with same sponsors:

Fudan UniversityHRYZ Biotech Co.+1 more
Collaborated on 1 trial
Similarity Score64%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of the Uterine CervixAnal Cancer
Similarity Score9%

Deborah E Citrin, M.D.

National Cancer Institute (NCI)

Related
13 trials

Shared therapeutic areas:

Anal CancerCancer of the Uterine Cervix
Similarity Score9%

Jun Zhang, master

Xiamen University

Related
12 trials

Shared therapeutic areas:

Cancer of the Uterine CervixAnal Cancer
Similarity Score9%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixCervical Carcinoma
Similarity Score9%

Jason Wu

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Related
31 trials

Shared therapeutic areas:

Cancer of the Uterine CervixCervical Carcinoma
Similarity Score9%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Cervical Carcinoma
Similarity Score4%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score4%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score4%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05952947Phase 1PrincipalInvestigator

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

Anal CancerCarcinoma of PenisCarcinoma of Vagina+3 more
Recruiting
NCT05357027Phase 1/2StudyDirector

HPV16 E6 TCR T Cells for Cervical Carcinoma

Cervical Carcinoma
Terminated
NCT07177716Phase 2/3PrincipalInvestigator

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

Cervical Cancer
Not Yet Recruiting

All 3 trials loaded